PROTECTION OF INFANTS AND CHILDREN AGAINST HAZARDS

Section 12.10 - Precautions to be observed in the use of dyes and inks containing aniline or nitrobenzene or other benzene derivatives for marking diapers and hospital linens

PROTECTION OF INFANTS AND CHILDREN AGAINST HAZARDS

12.10 Precautions to be observed in the use dyes and inks containing aniline or nitrobenzene or other benzene derivatives for marking diapers and hospital linens.

(a) Prohibition on use. No hospital, laundry or diaper service shall use inks or dyes containing aniline oil (aminobenzene) or oil of mirbane (nitrobenzene) or other benzene derivatives to stamp or otherwise mark diapers, sheets, gowns, towels or other clothing or linens unless the articles so marked are boiled by the agency doing the marking before they are delivered, stored or otherwise made available for use.

(b) Marking of containers. All containers used for dyes and inks containing aniline oil or oil of mirbane or other benzene derivatives used for marking diapers and hospital linens shall bear a label which conforms with the requirements of the sections of Part 9, supra, under heading "Warning Labels on Containers of Hazardous Substances" (õ 9.20 et seq.), and the label must also contain the statement, "DIAPERS, CLOTHING OR LINEN MARKED BY THIS DYE (OR INK) MUST BE LAUNDERED, INCLUDING BOILING, BEFORE BEING MADE AVAILABLE FOR USE."

Effective Date: 
Thursday, August 3, 1972
Doc Status: 
Complete

Section 12.11 Reserved

Section 12.12 - Warning label required on certain plastic material

12.12 Warning label required on certain plastic material. (a) Warning statement required. No person shall sell, offer for sale, or deliver, or offer for delivery, or give away any plastic bag or partial plastic bag intended for domestic or household use, or for packaging articles intended for domestic or household use, or which is so designed or decorated as to encourage its use as a toy, the length and width of which when added together totals 25 inches or more and the opening side of which is seven inches or more and the material of which is less than one mil (1/1,000 of an inch) in thickness; unless such plastic bag bears the following warning statement, or a warning statement which the Commissioner of Health has approved as the equivalent thereof:

"WARNING: To avoid danger of suffocation, keep this plastic bag away from babies and children. Do not use this bag in cribs, beds, carriages or play pens."

(b) Placement, printing of label. Such warning statement shall be imprinted in a prominent place on the plastic bag or shall appear on a label securely attached to the bag in a prominent place, and shall be printed in legible type which shall be contrasted by typography, layout or color from the contents of the bag and from other printed matter on the bag, if any.

(c) Size of print of label. The size of the print of such statement shall be as follows:

Total length and width of the bag Size of print

60 inches or more At least 24 point

40 inches to, but not including, 60 inches " " 18 "

30 inches to, but not including, 40 inches " " 14 "

25 inches to, but not including, 30 inches " " 10 "

Effective Date: 
Thursday, August 3, 1972
Doc Status: 
Complete

Section 12.13 - Determination of blood group and Rh type and administration of Rh immune globulin

12.13 Determination of blood group and Rh type and administration of Rh immune globulin. (a) It shall be the duty of the physician, licensed midwife or nurse practitioner attending a pregnant woman to take or cause to be taken a sample of her blood at the time of first examination or if this has not been done, as soon thereafter as practicable and prior to the time of delivery or other termination of pregnancy, whether induced or spontaneous. If the sample has not been taken and the pregnancy terminates as a result of an emergency, it shall be taken at the time of termination of the pregnancy. Such sample shall be submitted to an approved laboratory for the determination of blood group and Rh type.

(b) It shall further be the duty of the attending physician, licensed midwife or nurse practitioner to evaluate every such patient for the risk of sensitization to Rho (D) antigen and if the use of Rh immune globulin is indicated, and the patient consents, to cause an appropriate dosage thereof to be administered to her as soon as possible within 72 hours after delivery or other termination of pregnancy, whether induced or spontaneous.
 

Effective Date: 
Wednesday, July 19, 2000
Doc Status: 
Complete

Section 12.20 - Induced termination of pregnancy

12.20 Induced termination of pregnancy.

An induced termination of pregnancy with the intent to procure or induce miscarriage may be performed in other than a hospital or treatment center, as such terms are defined in the State Hospital Code (10 NYCRR Chapter V), only up to and including the twelfth week of pregnancy; thereafter it shall be performed in a hospital and only on an in-patient basis.

Effective Date: 
Sunday, September 1, 1974
Doc Status: 
Complete